Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,180 across all filing types
Latest filing 2023-07-10 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a compliance certificate addressed to the National Stock Exchange of India under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements), 2015. It details the loss of share certificates and requests stop transfer, signed by the Company Secretary. The document is short (1915 characters) and is a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which covers compliance documents and certifications that do not fit other categories.
2023-07-10 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 100% confidence The document is a disclosure under Regulation 31 of SEBI (Substantial Acquisitions of Shares and Takeovers) Regulations, 2011, which pertains to reporting substantial shareholding and changes therein. It details the promoter group shareholding percentages and names, with no indication of financial results, management changes, or other report types. The content matches the description of a Major Shareholding Notification, which involves notifying changes or status of significant share ownership levels.
2023-07-09 English
Disclosure in respect of allotment of 16139 shares under ESOP.
Regulatory Filings Classification · 95% confidence The document text contains only a digital signature block with no substantive content related to financial reports, regulatory filings, or corporate announcements. It is very short (516 characters) and does not include any financial data, report titles, or regulatory references. Therefore, it does not fit into any specific report category and is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit elsewhere.
2023-07-06 English
ESOP/ESOS/ESPS
Regulatory Filings Classification · 90% confidence The document text is extremely short (566 characters) and contains only a digital signature block with no substantive content related to financial performance, management changes, voting results, or any other specific filing category. There is no mention of any report, announcement, or regulatory filing content. Given the lack of any detailed information and the presence of a digital signature, this document most closely fits the fallback category for miscellaneous filings that do not fit other categories, i.e., Regulatory Filings (RNS).
2023-07-06 English
Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2023.
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2023. It is a confirmation certificate from the Registrar and Share Transfer Agent regarding dematerialisation of securities and compliance with regulatory requirements. The document is short (2458 characters) and serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of a report but a compliance certificate. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory compliance documents that do not fit other specific categories.
2023-07-05 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document text is extremely short (136 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report content, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2023-07-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.